Search - tctmd.com

Displaying 1 - 20 of 70

Sort: Relevancy | Date

News Daily News

Myocardial Ischemia and Mental Stress: Mechanisms Differ in Women and Men

Michael O'Riordan

December 21, 2017

News Daily News

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

Caitlin E. Cox

December 05, 2017

News Daily News

Burden of Readmission High in PAD Patients Following Revascularization

L.A. McKeown

December 04, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Shelley Wood

November 09, 2017

News Conference News TCT 2017

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Ashley Lyles

November 06, 2017

News Featured Fellow

Jonathan Schwartz, MD

Yael L. Maxwell

October 27, 2017

News Daily News

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Michael O'Riordan

October 24, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Daily News

Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies

Todd Neale

October 19, 2017

News Daily News

Multiarterial CABG Gets a Boost in Retrospective Analysis

Yael L. Maxwell

October 12, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

L.A. McKeown

September 15, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Daily News

Another Study Challenges Notion of ‘Healthy Obese’

L.A. McKeown

September 11, 2017

News Conference News ESC 2017

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Shelley Wood

August 28, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

Advertisement

Myocardial Ischemia and Mental Stress: Mechanisms Differ in Women and Men

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

Burden of Readmission High in PAD Patients Following Revascularization

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Jonathan Schwartz, MD

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies

Multiarterial CABG Gets a Boost in Retrospective Analysis

NOAC Bleeding Risk Rises With Several Drug Combinations

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

Another Study Challenges Notion of ‘Healthy Obese’

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content